NCT00580892

Brief Summary

The researcher can use Optical coherence tomography a near-infrared diode to emit light that can produce images of the specimen under investigation and provide information about tissue abnormalities without causing damage.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 20, 2007

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 27, 2007

Completed
10.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

October 20, 2022

Status Verified

October 1, 2022

Enrollment Period

11 years

First QC Date

December 20, 2007

Last Update Submit

October 19, 2022

Conditions

Disorder of Pleura and Pleural Cavity

Outcome Measures

Primary Outcomes (1)

  • histopathology

    up to 4 weeks

Study Arms (1)

Airway and Pleural Disorders

Optical Coherence Tomography imaging

Device: Optical Coherence Tomography imaging

Interventions

Optical Coherence Tomography imagingDEVICE

Optical Coherence Tomography imaging

Airway and Pleural Disorders

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population will be selcted from University of California Irvine Chao Cancer Center.

You may qualify if:

  • Adult 18 or older, male or female.
  • Plans for bronchoscopic with possible biopsy procedures.

You may not qualify if:

  • Age less than 18 years of age
  • Not plan for bronchoscopic with possible biopsy procedures.
  • Pregnant or breastfeeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pulmonary and Critical Care Medicine

Irvine, California, 92612, United States

Location

MeSH Terms

Conditions

Pleural Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Study Officials

  • Matthew Brenner, M.D

    Beckman Laser Institute

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Matthew Brenner, M.D.,Department of Pulmonary and Critical Care Medicine

Study Record Dates

First Submitted

December 20, 2007

First Posted

December 27, 2007

Study Start

July 1, 2007

Primary Completion

July 1, 2018

Study Completion

July 1, 2018

Last Updated

October 20, 2022

Record last verified: 2022-10

Locations

US(1)